rs202120461
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 1P and 13B. PP2BP4_StrongBP6BS1BS2
The NM_005120.3(MED12):c.3785G>A(p.Arg1262Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000281 in 1,208,445 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 14 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005120.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MED12 | NM_005120.3 | c.3785G>A | p.Arg1262Lys | missense_variant | 27/45 | ENST00000374080.8 | NP_005111.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MED12 | ENST00000374080.8 | c.3785G>A | p.Arg1262Lys | missense_variant | 27/45 | 1 | NM_005120.3 | ENSP00000363193.3 |
Frequencies
GnomAD3 genomes AF: 0.0000268 AC: 3AN: 112003Hom.: 0 Cov.: 23 AF XY: 0.0000293 AC XY: 1AN XY: 34163
GnomAD3 exomes AF: 0.0000513 AC: 9AN: 175357Hom.: 0 AF XY: 0.0000322 AC XY: 2AN XY: 62111
GnomAD4 exome AF: 0.0000283 AC: 31AN: 1096388Hom.: 0 Cov.: 32 AF XY: 0.0000359 AC XY: 13AN XY: 361956
GnomAD4 genome AF: 0.0000268 AC: 3AN: 112057Hom.: 0 Cov.: 23 AF XY: 0.0000292 AC XY: 1AN XY: 34227
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 29, 2013 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 26, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
FG syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 24, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at